Search

Your search keyword '"P. Hajek"' showing total 21 results

Search Constraints

Start Over You searched for: Author "P. Hajek" Remove constraint Author: "P. Hajek" Journal leukemia Remove constraint Journal: leukemia
21 results on '"P. Hajek"'

Search Results

2. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

3. Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

4. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

5. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

6. Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance

7. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination

8. Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma

9. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

10. Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network

11. Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis

13. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

16. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

17. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

18. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

19. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

20. Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

21. Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes

Catalog

Books, media, physical & digital resources